Advertisement

Catecholamines in Activation, Stereotypy, and Level of Mood

  • A. Randrup
  • I. Munkvad
  • R. Fog
  • I. H. Ayhan

Abstract

Studies of the effects of psychoactive drugs have contributed much to the present knowledge of the role of catecholamines in behavioral physiology. Since drugs are never completely specific, i.e., no drug acts on only one system in the brain, the knowledge derived from pharmacological experiments is beset with a corresponding uncertainty. Evidence from several experiments, preferably carried out using very different methods, is therefore necessary for conclusions about association between a specific system in the brain and a certain behavior. In the following we shall try to expound such evidence about the association of catecholaminergic systems in the brain with behavioral activation and stereotypy, and we shall explore the possible relations of animal experiments with clinical observations comprising also mental phenomena such as thinking and mood.

Keywords

Stereotyped Behavior Homovanillic Acid Vervet Monkey Brain Dopamine Selective Stimulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Alarcon, R. de, and Carney, M. W. P., 1969, Severe depressive mood changes following slow-release intramuscular fluphenazine injection, Brit. Med. J. 3: 564.PubMedGoogle Scholar
  2. Anggàrd, E., Jönsson, L. E., and Gunne, L.-M., 1971, Pharmacological blockade of amphetamine effects in subjects dependent on central stimulants, Acta Pharmacol. Toxicol. Suppl. 4: 2.Google Scholar
  3. Angrist, B., 1974, Amphetamine Psychosis, in: Catecholamines and Their Enzymes in the Neuropathology of Schizophrenia (S. Kety and S. Matthysse, eds.), J. Psychiat. Res. 11: 1.Google Scholar
  4. Angrist, B., Schweitzer, J., Friedhoff, A. J., Gershon, S., Hekimian, L. J., and Floyd, A., 1969, The clinical symptomatology of amphetamine psychosis and its relationship to amphetamine levels in urine, Int. Pharmacopsychiatry 2:125.Google Scholar
  5. Anlezark, G. M., Arbuthnott, G. W., Christie, J. E., and Crow, T. J., 1971, Role of cerebral dopamine in action of psychotropic drugs, Brit. J. Pharmacol. 41: 406.Google Scholar
  6. Arnfred, T., and Randrup, A., 1968, Cholinergic mechanism in brain inhibiting amphetamine-induced stereotyped behavior, Acta Pharmacol. Toxicol. 26: 384.Google Scholar
  7. Ashcroft, G. W., et al., 1972, Modified amine hypothesis for the etiology of affective illness, Lancet 1972: 573.Google Scholar
  8. Ayhan, I. H., and Randrup, A., 1972, Role of brain noradrenaline in morphine-induced stereotyped behavior, Psychopharmacologia 27: 203.PubMedGoogle Scholar
  9. Ayhan, I. H., and Randrup, A., 1973a, Behavioral and pharmacological studies on morphine-induced excitation of rats. Possible relation to brain catecholamines, Psychopharmacologia 29: 317.PubMedGoogle Scholar
  10. Ayhan, I. H., and Randrup, A., 1973b, Inhibitory effects of amphetamine, L-dopa and apomorphine on morphine-induced behavioral excitation of rats, Arch. Intern. Pharmacodyn. 204: 283.Google Scholar
  11. Benkert, 0., 1969, Measurement of hyperactivity in rats in a dose-response curve after intrahypothalamic norepinephrine injection, Life Sci. 8: 943.Google Scholar
  12. Bleuler, M., 1972, Lehrbuch der Psychiatrie, Springer-Verlag, Berlin, Heidelberg, New York. Boardman, R. H., and Fullerton, A. G., 1960, Iatrogenic parkinsonism, J. Mental Sci. 106: 1468.Google Scholar
  13. Bobon, J., Pinchard, A., Collard, J., and Bobon, D. P., 1972, Clinical classification of neuroleptics, with special reference to their antimanic, antiautistic, and ataraxic properties. Comprehensive Psychiat. 13: 123.Google Scholar
  14. Bobon, J., Bobon, D. P., Pinchard, A., Collard, J., Ban, T. A., Buck, R. de, Hippius, H., Lambert, P. A., and Vinar, O., 1972a, A new comparative physiognomy of neuroleptics: a collaborative clinical report. Acta Psychiat. Belgica 72: 542.Google Scholar
  15. Bohaeek, N., 1965, Discussion working group 4, in: Neuro-Psychopharmacology, ( D. Bente and P. B. Bradley, eds.), pp. 175–178, Elsevier Publishing Company, Amsterdam.Google Scholar
  16. Bowers, M. B., Jr., 1973, 5-Hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) following probenecid in acute psychotic patients treated with phenothiazines, Psychopharmacologia 28: 309.Google Scholar
  17. Caine, D. B., 1970, L-Dopa in the treatment of parkinsonism, Clin. Pharmacol. Therap. 11: 6.Google Scholar
  18. Carlsson, A., Persson, T., Roos, B. E., and Wâlinder, J., 1972, Potentiation of phenothiazines by a-methyltyrosine in treatment of chronic schizophrenia, J. Neural Transmission 33: 83.Google Scholar
  19. Carroll, B. J., and Sharp, P. T., 1972a, Monoamine mediation of the morphine-induced activation of mice, Brit. J. Pharmacol. 46: 124.Google Scholar
  20. Carroll, B. J., and Sharp, P. T., 1972b, An animal model of mania, Psychopharmacologia 26 (Suppl. 1972): 10.Google Scholar
  21. Cole, J. O., and Davis, J. M., 1968, Clinical efficacy of the phenothiazines as antipsychotic drugs, in: Psychopharmacology, (D. H. Efron, ed.), pp. 1057–1063, Public Health Service Publ. No. 1836, U.S. Government, Printing Office, Washington, D.C.Google Scholar
  22. Connell, P. H., 1956, Amphetamine psychosis, Thesis, Maudsley Hospital, University of London.Google Scholar
  23. Cools, A. R., 1971, The function of dopamine and its antagonism in the caudate nucleus of cats in relation to the stereotyped behaviour, Arch. Intern. Pharmacodyn, 194: 259.Google Scholar
  24. Cools, A. R., 1973, The Caudate Nucleus and Neurochemical Control of Behavior, Thesis, Universitet Nijmegen, Holland.Google Scholar
  25. Costall, B. and Naylor, R. J., 1974, Extrapyramidal and mesolimbic involvement with the stereotypic activity of d-and 1-amphetamine, European J. Pharmacol. 25: 121.Google Scholar
  26. Crow, T. J., 1972, A map of the rat mesencephalon for electrical self-stimulation, Brain Res. 36: 265.PubMedGoogle Scholar
  27. Daube, H., 1942, Pervitinpsychosen, Nervenarzt 15: 20.Google Scholar
  28. Delay, J., Pichot, P., Lemperiere, T., and Bailly, R., 1963, L’emploi des butyrophenones en psychiatrie etude statistique et psychometrique, in: Symposium Internazionale Sull’Haloperido! E Triperidol, pp. 305-319, Istituto Luso Farmaco D’Italia, Milano.Google Scholar
  29. Dyne, L. J., and Hughes, R. N., 1970, Effects of methylphenidate on activity and reactions to novelty in rats, Psychonomic Sci. 19 (5): 267.Google Scholar
  30. Ellinwood, E. H., 1967, Amphetamine psychosis: I. Description of the individuals and process, J. Nervous Mental Disease 144: 273.Google Scholar
  31. Ellinwood, E. H., 1969, Amphetamine psychosis: A multi-dimensional process, Seminars Psychiatry 1: 208.Google Scholar
  32. Ellinwood, E. H., 1971, Comparative methamphetamine intoxication in experimental animals, Pharmakopsychiat. Neuropsychopharmakol. 4: 357.Google Scholar
  33. Ellinwood, E. H. 1972, Amphetamine psychosis: individuals, setting, and sequences, in: Current Concepts of Amphetamine Abuse,(E. H. Ellinwood, and S. Cohen, eds.), pp. 143–157, U.S. Government Printing Office, Washington, D.C.Google Scholar
  34. Ellinwood, E. H., and Cohen, S. (eds.), 1972, Current Concepts of Amphetamine Abuse, U.S. Government Printing Office, Washington, D.C.Google Scholar
  35. Ellinwood, E. H., and Duarte-Escalante, 0., 1972, Chronic methamphetamine intoxication in three species of experimental animals, in: Current Concepts of Amphetamine Abuse, ( E. H. Ellinwood and S. Cohen, eds.), pp. 59–68, U.S. Government Printing Office, Washington, D.C.Google Scholar
  36. Ellinwood, E. H., Sudilovsky, and Nelson, L. M., 1973, Evolving behavior in the clinical and experimental amphetamine (model) psychosis, Am. J. Psychiat. 730 (10): 1088.Google Scholar
  37. Ernst, A. M., 1971, Chemical stimulation of central dopaminergic receptors in the striatal body of rats, in: The Correlation of Adverse Effects in Man with Observation in Animals (S. B. de Baker, ed.), pp. 18–23, Excerpta Med. Intern. Congr. Series 220, Amsterdam.Google Scholar
  38. Ernst, A. M., 1972, Relationship of the central effect of dopamine on gnawing compulsion syndrome in rats and the release of serotonin, Arch. Intern. Pharmacodyn. 199: 219.Google Scholar
  39. Fog, R., 1970, Behavioral effects in rats of morphine and amphetamine and of a combination of the two drugs, Psychopharmacologia 16: 305.PubMedGoogle Scholar
  40. Fog, R., 1972, On stereotype and catalepsy: studies on the effect of amphetamines and neuroleptics in rats, Acta Neurol. Scand. Suppl. 48: 50 (Thesis).Google Scholar
  41. Forrest, A., 1969, Depressive changes after fluphenazine treatment, Brit. Med. J. October:69. Fukui, K., and Tagaki, H., 1972, Effect of morphine on the cerebral contents of metabolites of dopamine in normal and tolerant mice: its possible relation to analgesic action, Brit. J. Pharmacol. 44: 45.Google Scholar
  42. Fukui, K., Shiomi, H., and Tagaki, H., 1972, Effect of morphine on tyrosine hydroxylase activity in mouse brain, European J. Pharmacol. 19: 123.Google Scholar
  43. Geyer, M., 1973, Dissociation of some behavioral effects of intraventricular dopamine and norepinephrine, Dissertation Abst. 33 (11): 5539.Google Scholar
  44. Geyer, M. A., and Segal, D. S., 1973, Differential effects of reserpine and a-methyl-p-tyrosine on norepinephrine and dopamine induced behavioral activity, Psychopharmacologia 29: 131.PubMedGoogle Scholar
  45. Goodwin, F. K., Post, R. M., Dunner, D. L., and Gordon, E. K., 1973, Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique, Am. J. Psychiat. 130 (1): 73.PubMedGoogle Scholar
  46. Guinard, L., 1890, Action physiologique de la morphine chez le chat, C. R. Acad, Sci. (Paris) 111: 981.Google Scholar
  47. Gunne, L. M., Änggârd, E., and Jönsson, L. E., 1970, Blockade of amphetamine effects in human subjects, in: International Institute on the Prevention and Treatment of Drug De pendence, I.C.A.A. ( A. Tongue and E. Tongue, eds.), pp. 249–255, Lausanne, Switzerland.Google Scholar
  48. Gunne, L. M.,.Änggârd, E., and Jönsson, L. E., 1972, Clinical trials with amphetamine-blocking drugs. Psychiat. Neurol. Neurochir. 75: 225.Google Scholar
  49. Harder, A., 1947, Uber Weckamin-Psychosen, Schweiz. Med. Wochschr. 37/38:982. Heimchen, H., and Hippius, H., 1967, Depressive Syndrome im Verlauf neuroleptischer Therapie, Nervenarzt 38 (10): 455.Google Scholar
  50. Herman, Z. S., 1970, The effects of noradrenaline on rat’s behaviour, Psychopharmacologia 16: 369.PubMedGoogle Scholar
  51. Hughes, R. N., 1972, Methylphenidate-induced inhibition of exploratory behaviour in rats, Life Sci. 11: 161.Google Scholar
  52. Isbell, H., 1971, Clinical aspects of the various forms of nonmedical use of drugs, Anesthesia Analgesia Current Res. 50: 886.Google Scholar
  53. Janssen, P. A. J., Niemegeers, C. J. E., and Schellekens, K. H. L., 1965, Is it possible to predict the clinical effects of neuroleptic drugs (major tranquilizers) from animal data? I. A rzneimit tel-Forsch. 15: 104.Google Scholar
  54. Janssen, P. A. J., Niemegeers, C. J. E., Schellekens, K. H. L., and Lenaerts, F. M., 1967, Is it possible to predict the clinical effects of neuroleptic drugs (major tranquilizers) from animal data? IV, Arzneimittel-Forsch. 17: 841.Google Scholar
  55. Jönsson, L. E., Änggârd, E., and Gunne, L.-M., 1971, Blockade of intravenous amphetamine euphoria in man, Clin. Pharmacol. Therap. 12: 889.Google Scholar
  56. Kalus, F., 1950, Über die psychotischen Bilder bei chronischem Pervitinmissbrauch (II), Psychiat. Neurol. Med. Psychol. 2:138:Google Scholar
  57. Kalus, F.; Kucher, I., and Zutt, J., 1942, Über Psychosen bei chronisher Pervitinmissbrauch, Nervenarzt 15: 8.Google Scholar
  58. Kellner, E., 1960, Preludinsucht and Preludinpsychose, Ther. Ggw. 11: 524.Google Scholar
  59. Kety, S., and Matthysse, S. (eds.), 1974, Catecholamines and their enzymes in the Neuropathology of Schizophrenia, J. Psychiatric Res. 11:1.Google Scholar
  60. Kjellberg, B., and Randrup, A., 1971, The effects of amphetamine and pimozide, a neuroleptic, on the social behavior of vervet monkeys (ceropithecus sp), in: Advances in Neuro-Psychopharmacology, ( O. Vinai, Z. Votava, and P. B. Bradley, eds.), pp. 305–310, North-Holland Publishing Company, Amsterdam. Avicenum, Czechoslovak Medical Press, Prague.Google Scholar
  61. Kjellberg, B., and Randrup, A., 1972a, Stereotypy with selective stimulation of certain items of behavior observed in amphetamine-treated monkeys (cercopithecus), Pharmakopsychiatr. Neuropsychopharmakol. 5: 1.Google Scholar
  62. Kjellberg, B., and Randrup, A., 1972b, Changes in social behaviour in pairs of vervet monkeys (cercopithecus) produced by single, low doses of amphetamine, Psychopharmacologia Suppl. 26: 117.Google Scholar
  63. Krueger, H., Eddy, N. B., and Sumwalt, M., 1941, The Pharmacology of the Opium Alkaloids, Part 1, Supplement 165, Public Health Reports, U.S. Government Printing Office, Washington, D.C.Google Scholar
  64. Kuschinsky, K., and Hornykiewicz, 0., 1973, Morphine-induced locomotor activity in mice: involvement of central dopaminergic and noradrenergic neurons, in: IV Congress of the Polish Pharmacological Society ( Kuschinsky, K., and Hornykiewicz, 0., ed.), p. 27, Lodz.Google Scholar
  65. Lat, J., 1965, The spontaneous exploratory reactions as a tool for psychopharmacological studies. A contribution towards a theory of contradictory results, in: Pharmacology of Conditioning, Learning and Retension ( M. Ya. Mikhel’son, V. G. Longo, and Z. Votava, eds.), pp. 47–66, Pergamon Press, Czechoslovak Medical Press, Prague.Google Scholar
  66. Lyon, M., and Randrup, A., 1972, The dose-response effect of amphetamine upon avoidance behavior in the rat seen as a function of increasing stereotype, Psychopharmacologia 23: 334.PubMedGoogle Scholar
  67. Mandell, A. J., Markham, C. H., Tallman, F. F., and Mandell, M. P., 1962, Motivation and ability to move, Am. J. Psychiat. 119: 554.Google Scholar
  68. McKenzie, G. M., 1972, Role of the tuberculum olfactorium in stereotyped behavior induced by apomorphine in the rat, Psychopharmacologia 23: 212.PubMedGoogle Scholar
  69. Mendels, J., Frazer, A., Fitzgerald, R. G., Ramsey, T. A., and Stokes, J. W., 1972, Biogenic amine metabolites in cerebrospinal fluid of depressed and manic patients, Science 175:1380.Google Scholar
  70. Mindham, R. H. S., 1970, Psychiatric symptoms in Parkinsonism, J. Neurol. Neurosurg. Psychiat. 33: 188.PubMedGoogle Scholar
  71. Müller-Calgan, H., and Hotovy, R., 1961, Verhaltensänderungen der Katze durch verschiedene zentralerregand wirkende Pharmaka, Arzneimittel-Forsch. 11: 642.Google Scholar
  72. Müller-Fahlbusch, H., 1972, Klinische and Katamnestische Untersuchungen zum Parkinsonismus, Georg Thieme Verlag, Stuttgart.Google Scholar
  73. Munkvad, I., and Randrup, A., 1966, The persistence of amphetamine stereotypies of rats in spite of strong sedation, Acta Psychiat. Scand. Suppl. 191: 178.Google Scholar
  74. Munkvad, I., and Randrup, A., 1970, Evidence indicating the role of brain dopamine in the psychopharmacology of schizophrenic psychoses, in: PsihoJarmakologija 2 ( N. Bohacek, ed.), pp. 45–47, Medicinska Naklada, Zagreb.Google Scholar
  75. Munkvad, I., Hein, G., and Herskin, B., 1971, The treatment of chronic schizophrenics with pimozide (Orap), Clin. Trials J. 8 (Suppl. II): 67.Google Scholar
  76. Nielsen, E. B., and Lyon, M., 1973, Drinking behavior and brain dopamine: Antagonistic effect of a neuroleptic drug (Pimozide) upon amphetamine-or apomorphine-induced hypodipsia, Psychopharmacologia 33: 299.PubMedGoogle Scholar
  77. Nordin, G., Ottosson, J.-O., and Ross, B.-E., 1971, Influence of convulsive therapy on 5hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid in endogeneous depression, Psychopharmacologia 20: 315.PubMedGoogle Scholar
  78. Norton, S., 1967, An analysis of cat behaviour using chlorpromazine and amphetamine, Intern J. Neuropharmacol. 6: 307.Google Scholar
  79. Nymark, M., 1972, Apomorphine provoked stereotypy in the dog, Psychopharmacologia 26: 361.PubMedGoogle Scholar
  80. O’Flanagan, P. M., and Taylor, R. B., 1950, A case of recurrent psychosis associated with amphetamine addiction, J. Mental Sci. 96: 1033.Google Scholar
  81. Papeschi, R., and McClure, D., 1971, Homovanillic and 5-hydroxyindoleacetic acid in cerebrospinal fluid of depressed patients. Arch. Gen. Psychiat. 25: 352.Google Scholar
  82. Papeschi, R., Randrup, A., and Lal, S., 1974a, Effect of ECT on dopaminergic and noradrenergic mechanisms. I. Effect on the behavioral changes induced by reserpine, a-methyl-ptyrosine or amphetamie, Psychopharmacologia 35: 149.PubMedGoogle Scholar
  83. Papeschi, R., Randrup A., and Munkvad, I., 19746, Effect of ECT on dopaminergic and noradrenergic mechanisms. II. Effect on dopamine and noradrenaline concentrations and turnovers, Psychopharmacologia 35:159.Google Scholar
  84. Patrick, H. T., and and Levy, D. M., 1922, Parkinson’s disease, Arch. Neurol. Psychiat. 7: 711.Google Scholar
  85. Pedersen, V., and Christensen, A. V., 1972, Antagonism of methyl-phenidate-induced stereotyped gnawing in mice, Acta Pharmacol. Toxicol. 31: 488.Google Scholar
  86. Piaget, J., 1964, Six Etudes de Psychologie, Gonthier, Paris.Google Scholar
  87. Post, R. M., Kotin, J., Goodwin, F. K., and Gordon, E. K., 1973, Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness, Am. J. Psychiat. 130 (1): 67.PubMedGoogle Scholar
  88. Randrup, A., and Munkvad, I., 1965, Special antagonism of amphetamine-induced abnormal behaviour, Psychopharmacologia 7: 416.PubMedGoogle Scholar
  89. Randrup, A., and Munkvad, I., 1967, Stereotyped activities produced by amphetamine in several animal species and man, Psychopharmacologia 11: 300.PubMedGoogle Scholar
  90. Randrup, A., and Munkvad, I., 1968, Behavioural stereotypies induced by pharmacological agents, Pharmakopsychiat. Neuropsychopharmakol. 1: 18.Google Scholar
  91. Randrup, A., and Munkvad, I., 1970, Biochemical, anatomical and psychological investigations of stereotyped behavior induced by amphetamine, in: Amphetamines and Related Compounds ( E. Costa and S. Garattini, eds.), pp. 695–713, Raven Press, New York.Google Scholar
  92. Randrup, A., and Munkvad, I., 1971, Behavioural toxicity of amphetamine studied in animal experiments, in: The Correlation of Adverse Effects in Man with Observations in Animals (S. B. de Baker, ed.), pp. 6–16, Excerpta Med. Congr. Series No. 220, Amsterdam.Google Scholar
  93. Randrup, A., and Munkvad, I., 1972, Evidence indicating an association between schizophrenia and dopaminergic hyperactivity in the brain, Orthomol. Psychiat. 1 (1): 2.Google Scholar
  94. Randrup, A., and Munkvad, I., 1975, Stereotyped behavior, in: Section 25, International Encyclopedia of Pharmacology and Therapeutics (O. Hornykiewicz, ed.), Pergamon Press, Toronto (in press).Google Scholar
  95. Randrup, A., and Munkvad, I., 1974, Pharmacology and physiology of stereotyped behavior, in: Catecholamines and Their Enzymes in the Neuropathology of Schizophrenia (S. Kety and S. Matthysse, eds.)J. Psychiatric Res. 11 :1.Google Scholar
  96. Randrup, A., Munkvad, I., and Udsen, P., 1963, Adrenergic mechanisms and amphetamine-induced abnormal behaviour, Acta Pharmacol. Toxicol. 20: 145.Google Scholar
  97. Randrup, A., Munkvad, I. and Scheel-Krüger, J., 1973, Mechanisms by which amphetamines produce stereotypy, aggression and other behavioural effects, in: Psychopharmacology, Sexual Disorders and Drug Abuse (T. Bau et al.,eds.), North Holland, Amsterdam, and Avicenum, Prague.Google Scholar
  98. Robbins, T., and Iversen, S. D., 1973, A dissociation of the effects of d-amphetamine on loco-motor activity and exploration in rats, Psychopharmacologia 28: 155.PubMedGoogle Scholar
  99. Robinson, P., and Daley, M., 1967, Apomorphine-induced reinforcement, Psychonomic Sci. 7: 117.Google Scholar
  100. Roffler-Tarlov, S., Sharman, D. F., and Tegerdine, P., 1971, 3,4-Dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the mouse striatum: a reflection of intra-and extra-neuronal metabolism of dopamine?, Brit. J. Pharmacol. 42: 343.Google Scholar
  101. Rolinski, Z., and Scheel-Krüger, J., 1973, The effect of dopamine and noradrenaline antagonists on amphetamine induced locomotor activity in mice and rats, Acta Pharmacol. Toxicol. 33: 385.Google Scholar
  102. Roos, B. E., and Sjöström, R., 1969, 5-hydroxyindoleacetic acid (and homovanillic acid) levels in the cerebrospinal fluid after probenecid application in patients with manic-depressive psychosis, Pharmacol. Clin. 1: 153.Google Scholar
  103. Rylander, G., 1969, Clinical and medico-criminological aspects of addition to central stimulating drugs, in: Abuse of Central Stimulants ( F. Sjoquist and M. Tottie, eds.), pp. 251–273, Almqvist and Wiksell, Stockholm.Google Scholar
  104. Rylander, G., 1971, Stereotypy in man following amphetamine abuse, in: The Correlation of Adverse Effects in Man with Observations in Animals (S. B. de Baker, ed.), pp. 28–31, Excerpta Med. Internl. Congr. Series No. 220, Amsterdam.Google Scholar
  105. Rylander, G., 1972, Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs, Psychiat. Neurol. Neurochir. 75: 203.PubMedGoogle Scholar
  106. Sano, I., and Nagasaka, 1956, Uber chronische Weckaminsucht in Japan, Fortschr. Neurol. Psychiat. 24: 391.PubMedGoogle Scholar
  107. Sayers, A. C., 1972, An investigation into hyperkinesia and akinesia induced by certain stimulant drugs, Thesis, University of Aston in Birmingham.Google Scholar
  108. Scheel-Krüger, J., 1972, Behavioural and biochemical comparison of amphetamine derivativesGoogle Scholar
  109. cocaine, benztropine and tricyclic antidepressant drugs, European J. Pharmacol. 18:63. Scher, J., 1966, Patterns and profiles of addiction and drug abuse, Arch. Gen. Psychiat. 15:539.Google Scholar
  110. Schi¢rring, E., 1971, Amphetamine-induced selective stimulation of certain behaviour items with concurrent inhibition of others in an open-field test with rats, Behaviour 34: 1.Google Scholar
  111. Schigrring, E., 1972, Social isolation and other behavioural changes in a group of three vervet monkeys (cercopithecus) produced by single, low doses of amphetamine, Psychopharmacologia Suppl. 26: 117.Google Scholar
  112. Schi¢rring, E., An open-field study on spontaneous locomotion with amphetamine-treated rats, In preparation.Google Scholar
  113. Schi¢rring, E., and Randrup, A., 1971, Social isolation and changes in the formation of groups induced by amphetamine in an open-field test with rats, Pharmakopsychiatr. Neuropsychopharmakol. 4: 2.Google Scholar
  114. Segal, D. S., and Mandell, A. J., 1970, Behavioral activation of rats during intraventricular infusion of norepinephrine, Proc. Natl. Acad. Sci. (U.S.) 66: 289.Google Scholar
  115. Segal, M., and Ropschitz, D., 1969, Depressive changes after fluphenazine treatment, Brit. Med. J. 3: 169.Google Scholar
  116. Simonson, M., 1964, Phenothiazine depressive reaction, J. Neuropsychiat. 5: 259.PubMedGoogle Scholar
  117. Sjöqvist, F., and Tottie, M., (eds.), 1969, Abuse of Central Stimulants, Almqvist and Wiksell, Stockholm.Google Scholar
  118. Sjöström, R., 1972, Studier av mano-depressiv psykos, Forskning och Praktik (Sandoz) 4:102. Soudijn, W., and Wijngaarden, I. van, 1972, Localization of [3H]pimozide in the rat brain in relation to its anti-amphetamine potency, J. Pharm. Pharmacol. 24: 773.Google Scholar
  119. Staehelin, J. E., 1941, Pervitin-Psychose, Z. Ges. Neurol. Psychiat. 173: 589.Google Scholar
  120. Tatetsu, S., 1960, Pervitin-psychosen, Folia Psychiat. Neurol. Japon. Suppl. 6: 25.Google Scholar
  121. Van, Praag, H. M., and Korf, J., 1971, Retarded depression and the dopamine metabolism, Psychopharmacologia 19: 199.Google Scholar
  122. Warburton, J. W., 1967, Depressive symptoms in Parkinson patients referred for thalamotomy, J. Neurol. Neurosurg. Psychiat. 30: 368.PubMedGoogle Scholar
  123. Willner, J. H., Samach, M., Angrist, B. M., Wallach, M. B., and Gershon, S., 1970, Drug-induced stereotyped behavior and its antagonism in dogs, Commun. Behay. Biol. 5: 135.Google Scholar
  124. York, D. H., 1972, Dopamine receptor blockage—A central action of chloropromazine on striatal neurones, Brain Res. 37: 91.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1975

Authors and Affiliations

  • A. Randrup
    • 1
  • I. Munkvad
    • 1
  • R. Fog
    • 1
  • I. H. Ayhan
    • 1
  1. 1.The Research Laboratory, Department ESct. Hans HospitalRoskildeDenmark

Personalised recommendations